Phase 2Data readout

Triplex

Co-infected w/ Cytomegalovirus (CMV) and Human immunodeficiency virus (HIV)

FBIOFortress Biotech

Expected catalystDecember 31, 2026Company guidance: Dec 31, 2026

Catalyst overview

Event details

Drug or asset: Triplex
Development stage: Phase 2
Event type: Data readout
Indication: Co-infected w/ Cytomegalovirus (CMV) and Human immunodeficiency virus (HIV)

Research summary

What is being tracked?

This catalyst tracks a Phase 2 data readout for Triplex in Co-infected w/ Cytomegalovirus (CMV) and Human immunodeficiency virus (HIV). The expected timing is based on the latest available company guidance and may change.

Development notes

05/14/26:- PR No update. 08/13/26:- Triplex Phase 2 data for HIV and CMV co-infection is expected by end of 2026.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source